Abstract: The present invention relates to VEGF-C or VEGF-D materials and methods for promoting growth and differentiation of neural stem cells, neuronal and neuronal precursor cells, oligodendrocytes and oligodendrocyte precursor cells and materials and methods for administering said cells to inhibit neuropathology.
Type:
Application
Filed:
September 23, 2004
Publication date:
March 6, 2008
Applicants:
INSTITUTE NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Inventors:
Kari Alitalo, Marika Karkkainen, Paula Haiko, Kirsi Sainio, Kirmo Wartiovaara, Jean L. Thomas, Anne Eichmann
Abstract: The invention concerns human papillomavirus (HPV) DNA and more particularly the probes derived from these papillomaviruses, as well as the methods of detecting HPV using these probes. These human papillomaviruses are designated as HPV-2d, HPV-10b, HPV-14a, HPV-14b, HPV-15, HPV-17a, HPV-17b, HPV-19, HPV-20, HPV-21, HPV-22, HPV-23, HPV-24, HPV-28, HPV-29, HPV-31, HPV-32, HPV-IP2 and HPV-IP4.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
March 2, 1999
Assignees:
Institute Pasteur, Institute Nationale de la Sante et de la Recherche Medicale
Inventors:
Gerard Orth, Sylvie Beaudenon, Michel Favre, Dina Kremsdorf, Odile Croissant, Gerard Pehau-Arnaudet